HLN Price Prediction Next Week
Analysis and Insights
News Sentiment and Recent Developments:
- Analyst Ratings: Karel Zoete from Kepler Capital has maintained a Buy rating on Haleon PLC (HLN) with a price target of 440.00 pence, while the current analyst consensus is a Moderate Buy with an average price target of 405.64 pence.
- Pfizer's Stake Sale: Pfizer sold its entire stake in Haleon, raising $3.1 billion, which marks a significant milestone for Haleon's independence and growth prospects.
- Insider Sentiment: Despite the positive analyst outlook, insider sentiment is negative, with an increase in share sales by insiders over the past quarter.
Technical Analysis:
- Current Price: 10.29
- RSI (14): 54.10 (Neutral)
- MACD: Slightly positive, indicating bullish momentum.
- Bollinger Bands: The stock is trading near the lower end of the Bollinger Bands, suggesting potential undervaluation or reduced volatility.
Fibonacci Levels:
- Pivot Point: 10.27
- Support Levels: 10.08 (S1), 9.96 (S2)
- Resistance Levels: 10.47 (R1), 10.59 (R2)
Price Prediction and Recommendation:
Based on the analysis, Haleon PLC (HLN) is expected to trade between 10.35 and 10.45 next week. The stock is likely to experience upward momentum due to positive analyst sentiment and growth projections, despite insider selling activity.
Recommendation: Buy HLN with a target price of 10.40.
HLN Similar Chart Price Prediction
The price of HLN is predicted to go up -9.13%, based on the high correlation periods with REGN. The similarity of these two price pattern on the periods is 90.91%.
HLN
REGN
Down: -9.13%Similarity: 90.91%
HLN Revenue Forecast
HLN EPS Forecast
HLN FAQs
What is HLN revenue forecast for next quarter？
HLN VS S&P500
We expect Haleon, with financial and operational independence, to bolster its portfolio through product innovation and tuck-in acquisitions and expand the strong foothold it has in the consumer self-care industry.
Haleon is well positioned to enjoy long-term macro trends including aging population, premiumization of consumer healthcare, and growing emerging markets.
Haleon can utilize its large salesforce and distribution network to continue rolling out brands in new markets and use its expertise to increase household penetration and build up market share.
HLN Analyst's Forecast
Rashad Kawan
Morgan Stanley
Buy
2024-09-20
Price Target
$9.9 → $11
Upside
+4.19%
Morgan Stanley raised the firm's price target on Haleon to $10.95 from $9.90 and keeps an Overweight rating on the shares. The firm also removed the shares as a Top Pick. As one of the best-performing stocks in European staples year-to-date, Haleon offers less absolute upside from here, the analyst tells investors in a research note. However, the firm continue to favors the company relative to other food alternatives.
